Dyne Therapeutics, Inc. (DYN)
15.44
+0.24
(+1.58%)
USD |
NASDAQ |
Oct 05, 16:00
15.44
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Price : 15.44 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 15.31 | 15.54 | 15.08 | 15.44 | 4.377M |
| Oct 02, 2026 | 16.03 | 16.03 | 15.08 | 15.20 | 2.534M |
| Oct 01, 2026 | 16.01 | 16.28 | 15.52 | 15.82 | 3.699M |
| Sep 30, 2026 | 16.05 | 16.80 | 15.92 | 16.11 | 4.456M |
| Sep 29, 2026 | 16.40 | 16.55 | 15.97 | 16.21 | 2.289M |
| Sep 28, 2026 | 15.86 | 16.43 | 15.63 | 16.34 | 2.306M |
| Sep 25, 2026 | 16.62 | 16.76 | 16.02 | 16.03 | 1.613M |
| Sep 24, 2026 | 16.09 | 16.64 | 15.88 | 16.51 | 3.198M |
| Sep 23, 2026 | 17.08 | 17.08 | 16.18 | 16.23 | 2.636M |
| Sep 22, 2026 | 17.39 | 17.59 | 17.06 | 17.14 | 2.627M |
| Sep 21, 2026 | 17.31 | 17.59 | 16.75 | 17.12 | 3.220M |
| Sep 18, 2026 | 18.07 | 18.15 | 16.96 | 17.11 | 4.850M |
| Sep 17, 2026 | 17.90 | 18.10 | 17.62 | 18.06 | 2.847M |
| Sep 16, 2026 | 18.37 | 18.37 | 17.09 | 17.30 | 2.156M |
| Sep 15, 2026 | 18.52 | 18.62 | 17.87 | 17.90 | 3.029M |
| Sep 14, 2026 | 18.40 | 19.14 | 18.26 | 18.52 | 3.197M |
| Sep 11, 2026 | 18.59 | 18.74 | 17.94 | 18.21 | 3.774M |
| Sep 10, 2026 | 19.02 | 19.02 | 17.93 | 18.42 | 4.710M |
| Sep 09, 2026 | 19.38 | 20.16 | 18.97 | 19.19 | 5.143M |
| Sep 08, 2026 | 17.08 | 20.91 | 17.00 | 20.31 | 17.17M |
| Sep 04, 2026 | 24.59 | 24.70 | 24.14 | 24.28 | 1.588M |
| Sep 03, 2026 | 25.26 | 25.39 | 24.60 | 24.95 | 1.453M |
| Sep 02, 2026 | 25.55 | 26.18 | 24.92 | 25.14 | 2.181M |
| Sep 01, 2026 | 24.99 | 25.40 | 24.72 | 25.10 | 1.629M |
| Aug 31, 2026 | 24.92 | 25.65 | 24.58 | 25.43 | 2.769M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Neurocrine Biosciences, Inc. | 144.21 |
| Agenus, Inc. | 8.73 |
| Amgen, Inc. | 402.98 |
| BioCryst Pharmaceuticals, Inc. | 8.10 |
| Imunon, Inc. | 1.24 |
Price Related Metrics
| Price to Book Value | 3.643 |
| Earnings Yield | -21.58% |
| Market Cap | 2.558B |